Skip to content
Trial Eligibility
Menu

Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant

NCT06609980

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Antibiotics are lifesaving therapeutic drugs which have been used by adults, children, and infants alike for decades. There is an increase in global use of antibiotics over the course of lifetime and earlier in lifetime, with some countries recording as high as 12 courses a year in children younger than two. While antibiotics are successful in eradicating many pathogenic bacteria, research has demonstrated significant effect on beneficial gut microbiota, including long-lasting shift in the dynamics, composition, richness, and maturity of the intestinal flora.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Antibiotic Treatment

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
1 month to 4 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Rutgers, The State University of New Jersey
Last updated on ClinicalTrials.gov
May 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 1

  • Rutgers Department of Biochemistry & Microbiology · New Brunswick, NJ

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.